Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.59
-0.08 (-1.11%)
At close: Jun 23, 2025, 4:00 PM
7.96
+0.38 (4.94%)
After-hours: Jun 23, 2025, 6:34 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $447.63 million as of June 23, 2025. Its market cap has decreased by -65.33% in one year.
Market Cap
447.63M
Enterprise Value
145.34M
1-Year Change
-65.33%
Ranking
Category
Stock Price
$7.59
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $447.63M, a decrease of -46.03%. That is a compound annual growth rate of -12.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 452.64M | -36.18% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.20B |
| Johnson & Johnson | 362.91B |
| AbbVie | 323.82B |
| Novo Nordisk | 309.67B |
| UnitedHealth Group | 272.34B |
| Abbott Laboratories | 231.43B |
| Novartis AG | 229.25B |
| AstraZeneca | 218.15B |